Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

OVID

Ovid Therapeutics Inc

Last Close
Jun 18 • 04:00PM ET
0.7879
Dollar change
-0.0017
Percentage change
-0.22 		%
Held by: VTI IWM VXF IWN IBB VTWO IWC VTWV BSVO DFAS Scroll to Statements
IndexRUT P/E- EPS (ttm)-0.72 Insider Own18.85% Shs Outstand70.69M Perf Week-74.67%
Market Cap55.89M Forward P/E- EPS next Y-0.63 Insider Trans0.14% Shs Float57.57M Perf Month-74.99%
Income-50.68M PEG- EPS next Q-0.22 Inst Own60.18% Short Float4.98% Perf Quarter-71.35%
Sales0.47M P/S118.92 EPS this Y-11.45% Inst Trans2.23% Short Ratio5.42 Perf Half Y-77.10%
Book/sh1.11 P/B0.71 EPS next Y23.16% ROA-36.86% Short Interest2.87M Perf Year-78.65%
Cash/sh1.27 P/C0.62 EPS next 5Y- ROE-50.87% 52W Range0.75 - 4.14 Perf YTD-75.53%
Dividend Est.- P/FCF- EPS past 5Y18.87% ROI-41.30% 52W High-80.96% Beta0.42
Dividend TTM- Quick Ratio10.47 Sales past 5Y275.67% Gross Margin-181.84% 52W Low4.81% ATR (14)0.30
Dividend Ex-Date- Current Ratio10.47 EPS Y/Y TTM1.71% Oper. Margin-13052.11% RSI (14)15.57 Volatility17.35% 7.37%
Employees40 Debt/Eq0.58 Sales Y/Y TTM283.30% Profit Margin-10701.82% Recom1.40 Target Price3.17
Option/ShortYes / Yes LT Debt/Eq0.57 EPS Q/Q12.72% Payout- Rel Volume7.90 Prev Close0.79
Sales Surprise184.07% EPS Surprise23.94% Sales Q/Q123.70% EarningsMay 14 BMO Avg Volume529.04K Price0.79
SMA20-73.52% SMA50-74.39% SMA200-76.35% Trades Volume4,180,360 Change-0.22%
Date Action Analyst Rating Change Price Target Change
Jun-18-24Downgrade Oppenheimer Outperform → Perform
Apr-30-24Initiated B. Riley Securities Buy $9
Apr-29-24Initiated H.C. Wainwright Buy $9
Apr-05-24Initiated Wedbush Outperform $8
Dec-21-23Initiated BTIG Research Buy $11
Oct-13-23Initiated Oppenheimer Outperform $8
Apr-20-21Downgrade Cantor Fitzgerald Buy → Neutral $4
Mar-03-21Downgrade RBC Capital Mkts Outperform → Sector Perform $5
Dec-02-20Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-02-20Downgrade Citigroup Buy → Neutral $10 → $4
Show Previous Ratings
Jun-18-24 09:51AM
Apple downgraded, Kroger upgraded: Wall Street's top analyst calls
(The Fly)
Jun-17-24 01:45PM
Is the Stock Market Closed on Juneteenth 2024?
(InvestorPlace) -76.00%
01:28PM
ACHR Stock Alert: Archer Aviation Strikes New Deal With Signature Aviation
(InvestorPlace)
01:03PM
AAN Stock Alert: The Aaron's Company Pops 33% on Take-Private Deal
(InvestorPlace)
12:38PM
Why Is Ovid Therapeutics (OVID) Stock Down 69% Today?
(InvestorPlace)
08:07AM
Takeda drug for rare types of epilepsy misses goal in late-stage trial
(BioPharma Dive)
06:55AM
Ovid Therapeutics Reports on Takeda's Announcement of Phase 3 Topline Study Results for Soticlestat
(GlobeNewswire)
May-28-24 01:09PM
3 Sorry Penny Stocks to Sell in May While You Still Can
(InvestorPlace)
May-20-24 06:00AM
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024
(InvestorPlace)
May-14-24 01:54PM
OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q1 2024
(InvestorPlace) +6.95%
09:10AM
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
(Zacks)
08:00AM
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
(GlobeNewswire)
May-13-24 07:00AM
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
(GlobeNewswire)
Apr-30-24 07:23AM
B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target
(MT Newswires) -8.68%
Apr-29-24 07:18AM
HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target
(MT Newswires) +7.74%
Apr-26-24 10:00AM
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
(Zacks)
Apr-04-24 08:00AM
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
Mar-17-24 05:19PM
5 Oversold Biotech Stocks To Buy Right Now
(Insider Monkey)
Mar-08-24 08:00AM
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
(GlobeNewswire)
Feb-28-24 08:00AM
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
(GlobeNewswire) -5.51%
Feb-06-24 08:00AM
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
(GlobeNewswire)
Dec-01-23 07:30AM
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
(GlobeNewswire) +7.39%
Nov-09-23 12:00PM
Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why
(Zacks) -5.65%
08:48AM
Q3 2023 Ligand Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
Nov-05-23 07:15PM
Ovid Therapeutics Inc (OVID) Reports Q3 2023 Financial Results
(GuruFocus.com)
Nov-03-23 08:00AM
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
(GlobeNewswire)
Oct-19-23 10:44AM
These 2 Strong Buy Penny Stocks Have Massive Upside Potential, Says Oppenheimer
(TipRanks)
Oct-18-23 08:00AM
Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026
(GlobeNewswire) -7.13%
Oct-10-23 08:00AM
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
(GlobeNewswire)
Sep-29-23 03:16PM
20 Countries With Highest Rate of Epilepsy
(Insider Monkey)
Sep-26-23 07:30AM
Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023
(GlobeNewswire)
Sep-20-23 07:30AM
Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
(GlobeNewswire)
Aug-30-23 08:00AM
Ovid Therapeutics to Participate in Upcoming September Investor Conferences
(GlobeNewswire) -6.07%
Aug-15-23 09:38PM
3 Very Promising Penny Stocks That Are Flying Under the Radar
(InvestorPlace) +5.29%
Aug-04-23 09:15AM
Ovid Therapeutics (OVID) Reports Q2 Loss, Lags Revenue Estimates
(Zacks) +5.42%
08:00AM
Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
(GlobeNewswire)
Aug-01-23 08:00AM
Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023
(GlobeNewswire)
Jul-31-23 09:29PM
Madison Avenue Partners, LP Boosts Stake in Ovid Therapeutics Inc
(GuruFocus.com)
Jul-02-23 10:00AM
Ovid Therapeutics Inc.'s (NASDAQ:OVID) hedge funds investors lost 12% last week but have benefitted from longer-term gains
(Simply Wall St.)
Jun-28-23 08:00AM
Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer
(GlobeNewswire)
Jun-26-23 08:00AM
Ovid Therapeutics Added to Russell 3000® Index
(GlobeNewswire) -8.58%
May-22-23 06:43AM
Companies Like Ovid Therapeutics (NASDAQ:OVID) Are In A Position To Invest In Growth
(Simply Wall St.)
May-05-23 08:45AM
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
(Zacks)
07:30AM
Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
(GlobeNewswire)
May-01-23 06:00AM
Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors
(GlobeNewswire)
Apr-27-23 02:30PM
Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology Annual Meeting
(GlobeNewswire) +8.73%
Apr-12-23 12:00PM
Ovid Therapeutics (OVID) Upgraded to Buy: Here's What You Should Know
(Zacks) +6.57%
Apr-11-23 06:51AM
Ovid Therapeutics (NASDAQ:OVID) shareholders have endured a 73% loss from investing in the stock five years ago
(Simply Wall St.) +7.45%
Apr-10-23 08:00AM
Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
Mar-15-23 06:21AM
Ovid Therapeutics Full Year 2022 Earnings: Beats Expectations
(Simply Wall St.)
Mar-13-23 08:00AM
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results
(GlobeNewswire)
Mar-09-23 08:00AM
Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum
(GlobeNewswire) -10.42%
Mar-08-23 08:00AM
Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures
(GlobeNewswire)
Feb-28-23 08:00AM
Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference
(GlobeNewswire)
Feb-08-23 08:00AM
Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments
(GlobeNewswire) -5.14%
Jan-22-23 07:37AM
Ovid Therapeutics Inc. (NASDAQ:OVID) has caught the attention of institutional investors who hold a sizeable 29% stake
(Simply Wall St.)
Jan-05-23 08:00AM
Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial
(GlobeNewswire)
Dec-02-22 10:00AM
Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)
(GlobeNewswire)
Nov-17-22 07:23AM
Is Ovid Therapeutics (NASDAQ:OVID) In A Good Position To Deliver On Growth Plans?
(Simply Wall St.)
Nov-08-22 08:00AM
Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
(GlobeNewswire)
Oct-18-22 08:57AM
Ovid Therapeutics (NASDAQ:OVID) shareholders have endured a 77% loss from investing in the stock five years ago
(Simply Wall St.)
Sep-27-22 08:00AM
Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference
(GlobeNewswire)
Sep-26-22 09:21AM
10 Best Biotech Stocks Under $10
(Insider Monkey)
Sep-07-22 08:00AM
Ovid Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
(GlobeNewswire)
Aug-14-22 10:40AM
Is Ovid Therapeutics Inc.'s (NASDAQ:OVID) Shareholder Ownership Skewed Towards Insiders?
(Simply Wall St.)
Aug-09-22 08:00AM
Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
(GlobeNewswire)
Jun-10-22 07:41AM
We Think Ovid Therapeutics (NASDAQ:OVID) Needs To Drive Business Growth Carefully
(Simply Wall St.)
Jun-06-22 08:00AM
Ovid Therapeutics Presents Preclinical Data on OV329 at the Epilepsy Foundation Pipeline Conference
(GlobeNewswire)
May-11-22 06:55AM
Investors in Ovid Therapeutics (NASDAQ:OVID) have unfortunately lost 80% over the last five years
(Simply Wall St.) -10.79%
May-10-22 08:00AM
Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
(GlobeNewswire)
Apr-26-22 07:17AM
3 Biotech Stocks Under $10 to Add to Your Buy List
(InvestorPlace)
Apr-08-22 08:00AM
Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
Mar-15-22 08:00AM
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results
(GlobeNewswire)
Mar-07-22 01:06PM
Do Institutions Own Ovid Therapeutics Inc. (NASDAQ:OVID) Shares?
(Simply Wall St.)
Mar-04-22 08:00AM
Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference
(GlobeNewswire)
Feb-28-22 01:51PM
Ovid Pharmaceuticals CEO details biotech pledge to cut ties with Russia
(Yahoo Finance Video)
Feb-08-22 08:00AM
Healx and Ovid Therapeutics to Enter Strategic Partnership
(GlobeNewswire)
Jan-04-22 08:01AM
Is Ovid Therapeutics Inc.'s (NASDAQ:OVID) Latest Stock Performance Being Led By Its Strong Fundamentals?
(Simply Wall St.)
Jan-03-22 07:25AM
Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact
(Benzinga)
06:30AM
Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators
(GlobeNewswire)
Nov-10-21 08:30AM
Ovid Therapeutics Reports Third Quarter 2021 Business Update, Corporate Highlights and Financial Results
(GlobeNewswire)
Nov-05-21 12:03PM
Ovid Therapeutics (NASDAQ:OVID) investors are sitting on a loss of 34% if they invested three years ago
(Simply Wall St.)
Oct-07-21 08:30AM
Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of Directors
(GlobeNewswire)
Sep-07-21 08:00AM
Ovid Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
(GlobeNewswire)
Sep-06-21 12:58PM
Is Ovid Therapeutics Inc. (NASDAQ:OVID) Popular Amongst Insiders?
(Simply Wall St.)
Aug-16-21 08:00AM
Ovid Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights
(GlobeNewswire) -7.43%
Jul-08-21 04:30PM
Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities
(GlobeNewswire)
Jul-07-21 08:00AM
Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
(GlobeNewswire)
Jul-06-21 07:01AM
Should Weakness in Ovid Therapeutics Inc.'s (NASDAQ:OVID) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
(Simply Wall St.)
Jun-04-21 08:00AM
Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer
(GlobeNewswire)
May-26-21 08:00AM
Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board
(GlobeNewswire)
May-24-21 07:52AM
Zacks Industry Outlook Highlights: Moderna, Amgen, BioNTech, Repligen Corp and Ovid Therapeutics
(Zacks)
May-21-21 08:46AM
Zacks Industry Outlook Highlights: Regeneron, Gilead Sciences, Amgen, Biogen, BioNTech, Repligen and Ovid Therapeutics
(Zacks)
May-20-21 09:29AM
3 Biotech Stocks to Keep an Eye On Amid the Coronavirus Mayhem
(Zacks)
May-13-21 04:05PM
Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
(GlobeNewswire) -5.71% +8.48%
May-12-21 08:00AM
Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
(GlobeNewswire)
May-07-21 08:42AM
Ovid Therapeutics Inc. (NASDAQ:OVID) Is About To Turn The Corner
(Simply Wall St.)
Apr-30-21 11:37AM
HMNY Stock & 7 Other Reddit Penny Stocks Hoping for a Takeover
(InvestorPlace) -5.17%
Apr-20-21 08:00AM
Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board
(GlobeNewswire)
Apr-19-21 09:16AM
Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions
(Benzinga)
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN JEREMY MCEOMar 18 '24Buy2.7618,24850,3643,616,715Mar 20 05:22 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • careers • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.